Prescription drugs
-
PublishedNovember 2, 2021
Democrats reach deal on lowering drug prices; Biden upbeat on Manchin
Democrats are looking to cap out-of-pocket Medicare drug costs at $2,000 and reduce the price of insulin, as part of President Biden's $1.75 trillion domestic policy proposal.
-
PublishedJuly 29, 2021
Our View: Opioid settlement funds must address addiction crisis
Deals are being reached with the companies responsible for shipping habit-forming medications across the U.S., and the proceeds must be used wisely.
-
PublishedJuly 2, 2021
Commentary: The Alzheimer’s mistake by the FDA is already getting worse
Now drugmaker Eli Lilly is pushing forward with another unproven treatment on the basis of limited evidence.
-
PublishedJune 23, 2021
Commentary: Medicare must study unproven, expensive Alzheimer’s drug
Taxpayers and patients cannot afford to pay a high price for a treatment not known to be effective.
-
PublishedJune 17, 2021
Commentary: Generic prescriptions deliver savings for Maine patients
An op-ed and an editorial praising proposed state regulations overlook the fact that brand-name drugs are consistently more costly to Maine.
-
PublishedJune 12, 2021
Another View: Alzheimer’s drug furor highlights U.S. health system’s failures
Is aducanumab a breakthrough or a boondoggle? U.S. health policy offers reason to worry.
-
PublishedJune 11, 2021
Our View: Maine prescription drug bills offer relief to stressed families
The proposals would help limit the constant price increases, which cost Mainers in more ways than one.
-
PublishedJune 10, 2021
Maine Voices: Legislators must take action to keep prescription drug prices in line
Lawmakers should not yield to intimidation from those who profit by jacking up prices on medicines Mainers need.
-
PublishedJune 8, 2021
Commentary: Congress should stop rewarding Big Pharma with tax breaks for gouging patients
Maine’s congressional delegation should push to eliminate loopholes that allow this industry to dodge paying its fair share.
-
PublishedMay 27, 2021
Legislative panel votes down bill to penalize drug companies for price gouging
The pharmaceutical industry has made it clear that it will sue Maine if the state approves the ‘excessive pricing’ bill, which now goes to the full Legislature.
- ← Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next Page →